Speaker illustration

Professor Naohiko Takahashi

Oita University Faculty of Medicine, Oita (Japan)

Member of:

European Society of Cardiology

Dr. Takahashi received his MD from Oita University, Japan in 1988 and undertook Internal Medicine and Physiology training at Oita between 1988 and 1993. Following obtaining his PhD, he transferred to Mayo Clinic, Department of Cardiovascular Medicine and Pharmacology between 1993-1994. He is presently Chair in Department of Cardiology and Clinical Examination at the Oita University. He is Associate Editor of Circulation Journal, Journal of Cardiology, and International Heart Journal. His research focuses on mechanisms of atrial fibrillation, particularly inflammatory atrial fibrosis. He also researches risk stratification of idiopathic ventricular fibrillation, including Brugada syndrome and early repolarization syndrome. He has supervised over 30 research trainees and published over 180 papers in peer-review journal.

Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study

Event: ESC Congress 2019

Topic: Anticoagulants

Session: Perspectives on anticoagulation across cardiovascular disease


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb